Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55:2789–800.
Gehlen J, Stundl A, Debiec R, Fontana F, Krane M, Sharipova D, et al. Elucidation of the genetic causes of bicuspid aortic valve disease. Cardiovasc Res. 2023;119:857–66.
Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270–4.
Gould RA, Aziz H, Woods CE, Seman-Senderos MA, Sparks E, Preuss C, et al. ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm. Nat Genet. 2019;51:42–50.
Tan HL, Glen E, Topf A, Hall D, O’Sullivan JJ, Sneddon L, et al. Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation. Hum Mutat. 2012;33:720–7.
Wunnemann F, Tas-Shma A, Preuss C, Leclerc S, Piet van Vliet P, Oneglia A, et al. Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. Nat Genet. 2020;52:40–7.
Xu Y-J, Di R-M, Qiao Q, Li X-M, Huang R-T, Xue S, et al. GATA6 loss-of-function mutation contributes to congenital bicuspid aortic valve. Gene. 2018;663:115–20.
Li R-G, Xu Y-J, Wang J, Liu X-Y, Yuan F, Huang R-T, et al. GATA4 loss-of-function mutation and the congenitally bicuspid aortic valve. Am J Cardiol. 2018;121:469–74.
Thiem CE, Stegmann JD, Hilger AC, Waffenschmidt L, Bendixen C, Köllges R, et al. Re-sequencing of candidate genes FOXF1, HSPA6, HAAO, and KYNU in 522 individuals with VATER/VACTERL, VACTER/VACTERL-like association, and isolated anorectal malformation. Birth Defects Res. 2022;114:478–86.
Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35:1978–80.
Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnel SK, Baheti A, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877–85.
Montanucci L, Brünger T, Boßelmann CM, Ivaniuk A, Pérez-Palma E, Lhatoo S, et al. Evaluating novel in silico tools for accurate pathogenicity classification in epilepsy-associated genetic missense variants. Epilepsia. 2024;65:3655–63.
Ponińska JK, Bilińska ZF, Truszkowska G, Michalak E, Podgórska A, et al. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections. J Transl Med. 2022;20:42.
Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet. 2012;91:224–37.
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–9.
Cheng J, Novati G, Pan J, Bycroft C, Žemgulytė A, Applebaum T, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381:eadg7492.
Dargis N, Lamontagne M, Gaudreault N, Sbarra L, Henry C, Pibarot P, et al. Identification of gender-specific genetic variants in patients with bicuspid aortic valve. Am J Cardiol. 2016;117:420e426.
Gago-Díaz M, Brion M, Gallego P, Calvo F, Robledo-Carmona J, Saura D, et al. The genetic component of bicuspid aortic valve and aortic dilation. Anexome-wide association study. J Mol Cell Cardiol. 2017;102:3–9.
Gillis E, Kumar AA, Luyckx I, Preuss C, Cannaerts E, van de Beek G, et al. Candidate gene resequencing in a large bicuspid aortic valve-associated thoracic aortic aneurysm cohort: SMAD6 as an important contributor. Front Physiol. 2017;8:400.
Pepe G, Nistri S, Giusti B, Sticchi E, Attanasio M, Porciani C, et al. Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome. BMC Med Genet. 2014;15:23.